Literature DB >> 32637922

Prevalence of Juvenile Fibromyalgia Syndrome Among Children and Adolescents and its Relationship With Academic Success, Depression and Quality of Life, Çorum Province, Turkey.

Ayla Çagliyan TÜrk1, Füsun Şahİn2.   

Abstract

OBJECTIVES: This study aims to determine the frequency of juvenile fibromyalgia syndrome (JFMS) among children and adolescents in Çorum Province, Turkey, and its impact by comparing the levels of academic success, depression and quality of life (QoL) in individuals with and without JFMS. PATIENTS AND METHODS: This was a cross-sectional study on 476 children and adolescents (245 boys, 231 girls; mean age 13.81±2.3 years; range, 9 to 17 years). The control group (non-JFMS group) consisted of 105 age- and sex-matched healthy participants (75 girls, 30 boys; mean age 14.1±1.8 years; range; 9 to 17 years). Participants' sociodemographic data, parental information, and school achievement in addition to data on chronic illness and drug use were collected via questionnaires (depression and QoL). A tender point (TP) examination was performed on each participant.
RESULTS: Thirty-five (7.35%) of the participants (girls, n=25; boys, n=10) were diagnosed with JFMS. The number of minor JFMS diagnostic criteria, number of TPs, depression level and number of days the participants were absent from school were significantly higher in the JFMS group compared with the non-JFMS group (p<0.05). The mean grade point scores of the JFMS group were significantly lower than those of the non-JFMS group (p<0.05). The QoL subgroup scores as assessed by physical functioning, emotional functioning, social functioning and school-related problems of the JFMS group were significantly lower than the non-JFMS group (p<0.05). Age had a statistically significant negative correlation with QoL and school-related problems (r= -0.421, r= -0.494; p<0.05, respectively). Depression was negatively correlated with QoL and school-related problems (r= -0.672, r= -0.731; p<0.05, respectively).
CONCLUSION: Juvenile fibromyalgia syndrome affects QoL and can lead to school absenteeism, poor academic performance, depression and anxiety among the school-age population. Early identification of JFMS and early intervention may be the most effective strategy for preventing problems in later life.
Copyright © 2020, Turkish League Against Rheumatism.

Entities:  

Keywords:  Depression; juvenile fibromyalgia syndrome; quality of life; school absenteeism; school success

Year:  2019        PMID: 32637922      PMCID: PMC7322312          DOI: 10.5606/ArchRheumatol.2020.7458

Source DB:  PubMed          Journal:  Arch Rheumatol        ISSN: 2148-5046            Impact factor:   1.472


  35 in total

1.  A Qualitative Examination of a New Combined Cognitive-Behavioral and Neuromuscular Training Intervention for Juvenile Fibromyalgia.

Authors:  Susmita Kashikar-Zuck; Susan T Tran; Kimberly Barnett; Maggie H Bromberg; Daniel Strotman; Soumitri Sil; Staci M Thomas; Naomi Joffe; Tracy V Ting; Sara E Williams; Gregory D Myer
Journal:  Clin J Pain       Date:  2016-01       Impact factor: 3.442

2.  Long-term outcomes of adolescents with juvenile-onset fibromyalgia in early adulthood.

Authors:  Susmita Kashikar-Zuck; Natoshia Cunningham; Soumitri Sil; Maggie H Bromberg; Anne M Lynch-Jordan; Daniel Strotman; James Peugh; Jennie Noll; Tracy V Ting; Scott W Powers; Daniel J Lovell; Lesley M Arnold
Journal:  Pediatrics       Date:  2014-02-24       Impact factor: 7.124

Review 3.  Fibromyalgia: Treating Pain in the Juvenile Patient.

Authors:  Sabrina Gmuca; David D Sherry
Journal:  Paediatr Drugs       Date:  2017-08       Impact factor: 3.022

4.  PedsQL 4.0: reliability and validity of the Pediatric Quality of Life Inventory version 4.0 generic core scales in healthy and patient populations.

Authors:  J W Varni; M Seid; P S Kurtin
Journal:  Med Care       Date:  2001-08       Impact factor: 2.983

Review 5.  Juvenile Fibromyalgia: Different from the Adult Chronic Pain Syndrome?

Authors:  Susmita Kashikar-Zuck; Christopher King; Tracy V Ting; Lesley M Arnold
Journal:  Curr Rheumatol Rep       Date:  2016-04       Impact factor: 4.592

6.  Cross-Sectional Study of Young Adults Diagnosed With Juvenile Fibromyalgia: Social Support and Its Impact on Functioning and Mood.

Authors:  Anne M Lynch-Jordan; Soumitri Sil; Maggie Bromberg; Tracy V Ting; Susmita Kashikar-Zuck
Journal:  J Adolesc Health       Date:  2015-09-12       Impact factor: 5.012

7.  The Treatment of Juvenile Fibromyalgia with an Intensive Physical and Psychosocial Program.

Authors:  David D Sherry; Lori Brake; Jenna L Tress; Jennifer Sherker; Katherine Fash; Kelly Ferry; Pamela F Weiss
Journal:  J Pediatr       Date:  2015-07-21       Impact factor: 4.406

8.  Juvenile primary fibromyalgia syndrome. A clinical study of thirty-three patients and matched normal controls.

Authors:  M B Yunus; A T Masi
Journal:  Arthritis Rheum       Date:  1985-02

Review 9.  Juvenile fibromyalgia: current status of research and future developments.

Authors:  Susmita Kashikar-Zuck; Tracy V Ting
Journal:  Nat Rev Rheumatol       Date:  2013-11-26       Impact factor: 20.543

Review 10.  School Anxiety in Children and Adolescents with Chronic Pain.

Authors:  K E Jastrowski Mano
Journal:  Pain Res Manag       Date:  2017-09-26       Impact factor: 3.037

View more
  3 in total

Review 1.  VOSviewer-Based Bibliometric Network Analysis for Evaluating Research on Juvenile Primary Fibromyalgia Syndrome (JPFS).

Authors:  Alessandro Vittori; Marco Cascella; Marianna Leonardi; Federica Monaco; Davide Nocerino; Arturo Cuomo; Alessandro Ottaiano; Francesco Perri; Ilaria Mascilini; Elisa Francia; Emiliano Petrucci; Franco Marinangeli; Sergio Giuseppe Picardo
Journal:  Children (Basel)       Date:  2022-04-28

2.  The Challenges of Identifying Fibromyalgia in Adolescents.

Authors:  Elisha E Peterson; Caylynn Yao; Sangeeta D Sule; Julia C Finkel
Journal:  Case Rep Pediatr       Date:  2022-04-08

3.  Paediatric chronic pain prevalence in low- and middle-income countries: A systematic review and meta-analysis.

Authors:  Zi Wei Liao; Chi Le; J Matthew Kynes; Jonathan A Niconchuk; Emilia Pinto; Heather E Laferriere; Camila B Walters
Journal:  EClinicalMedicine       Date:  2022-02-12
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.